Cite
Abiko Y, Gotoh H, Yokoyama T, et al. Bopindolol and its metabolite 18-502 attenuate regional myocardial acidosis during partial occlusion of the coronary artery in dogs. Arch Int Pharmacodyn Ther. 1994;327(1):40-55
Abiko, Y., Gotoh, H., Yokoyama, T., Abiko, T., Hashizume, H., & Akiyama, K. (1994). Bopindolol and its metabolite 18-502 attenuate regional myocardial acidosis during partial occlusion of the coronary artery in dogs. Archives internationales de pharmacodynamie et de therapie, 327(1), 40-55.
Abiko, Y, et al. "Bopindolol and its metabolite 18-502 attenuate regional myocardial acidosis during partial occlusion of the coronary artery in dogs." Archives internationales de pharmacodynamie et de therapie vol. 327,1 (1994): 40-55.
Abiko Y, Gotoh H, Yokoyama T, Abiko T, Hashizume H, Akiyama K. Bopindolol and its metabolite 18-502 attenuate regional myocardial acidosis during partial occlusion of the coronary artery in dogs. Arch Int Pharmacodyn Ther. 1994 Jan-Feb;327(1):40-55. PMID: 7944827.
Copy
Download .nbib